Elekta President and CEO Tomas Puusepp Pledges Support in Addressing Global Cancer Challenge at World Cancer Leaders' Summit in Montreal

MONTREAL, Aug. 27, 2012 /PRNewswire/ -- Tomas Puusepp, President and CEO of Elekta, a global leader in developing innovative solutions for treating cancer, will be participating in the 2012 World Cancer Leaders' Summit today in Montreal. Elekta also is a sponsor and exhibitor for the biennial UICC World Cancer Congress, Aug. 27-30 at the Palais des congres de Montreal.

"We are dedicated to contributing our time, talents and resources to advancements in cancer care," says Puusepp. "I'm honored to join international cancer leaders in Montreal where Elekta is engaged and committed to bringing hope to patients with cancer."

The World Cancer Congress gives participants the opportunity to exchange ideas and learn about solutions for reducing the impact of cancer on communities around the world. It will highlight how knowledge gained through research and practice can benefit people living with and affected by cancer.

Puusepp notes that Elekta is committed to supporting local cancer communities in Montreal and throughout Canada. Montreal is home to one of Elekta's key research and development centers, and some of the company's Canadian customers include McGill University Hospital Centre and Cancer Care Ontario, one of North America's largest cancer centers.

"We are privileged to have played a part in the establishment of this important research and development facility in Canada," he says. "Our Montreal team has been dedicated to developing effective, patient-friendly cancer management solutions that are used every day to help individuals with cancer worldwide."

At the Congress's Global Village, Elekta will share its products and insights at its exhibit, which will feature three of its industry leading solutions for advanced radiation therapy:

• MOSAIQ® Oncology Information System puts the patient at the center of the cancer care universe by enabling real-time data access that centralizes the patient's electronic medical record (EMR). MOSAIQ facilitates coordination of the treatment process from referral to therapy and beyond. Quebec's Centre de Sante et de Services Sociaux de Laval selected MOSAIQ for both the radiation oncology and medical oncology departments at its new cancer facility, Centre Integre de Cancerologie de Laval, which opened earlier this year.
• Clarity soft tissue visualization software, a non-invasive technology for image-guided radiation therapy that avoids adding any imaging dose or requiring surgically implanted markers.
• METRIQ® cancer registry software, an electronic repository for collecting patient data and using it to learn more about cancer. With METRIQ, clinicians, planners and funders of cancer services, and cancer research obtain quality clinical data and clinical collaboration is fostered both regionally and worldwide.

"Considering the global burden of disease, cancer ranks as a leading cause of death, accounting for 7.6 million deaths – 13 percent of all deaths – in 2008, according to the World Health Organization," Puusepp observes. "The mission of Elekta and other providers is clear, and we are honored that Elekta solutions in particular are used in 6,000 hospitals worldwide to improve, prolong and save the lives of nearly one million patients every year."

For further information, please contact:
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, email: [email protected]
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: [email protected]
Time zone: ET: Eastern Time

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

SOURCE Elekta